FDA Used Critically Flawed Risk-Benefit Analysis to Justify COVID Vaccines For Children

The US FDA used a ‘critically flawed’ risk-benefit analysis to ‘justify’ COVID vaccines for children. The hazards of COVID-19 vaccination exceed the advantages for millions of children.

On October 29, 2021, the US Food and Drug Administration (FDA) issued Pfizer's COVID-19 vaccine Emergency Use Authorization (EUA) for children aged 5 to 11.

On Nov. 2, 2021, the Centers for Disease Control and Prevention (CDC) recommended Pfizer's COVID-19 vaccination for 28 million American kids under...

Subscribe to view this content.

Explore exclusive GGI coverage of Donald Trump’s assassination attempt.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].